Prothrombin
(AGVAZMGAQJOSFJ-UHFFFAOYSA-M)
Structure
- SMILES
- OCC1OC(C(C1OP(=O)(OC(CNC(=O)CCC1(C)/C/2=C(\C)/C3=N/C(=C\C4=N/C(=C(\C5=NC(C(C1CC(=O)N)[N-]2)(C)C(C)(CC(=O)N)C5CCC(=O)N)/C)/C(C4CCC(=O)N)(C)CC(=O)N)/C(C3CCC(=O)N)(C)C)C)O)O)n1cnc2c1cc(C)c(c2)C.[C-]#N.[Co+2]
- Molecular Formula:
- C63H89CoN14O14P
- Molecular Weight:
- 1356.370
- Log P:
- 6.2737
- Hydrogen Bond Acceptor:
- 27
- Hydrogen Bond Donor:
- 10
- TPSA:
- 481.59
- CAS Number(s):
- 68-19-9
Synonym(s)
1.
Prothrombin
2.
Coagulation Factor II
3.
Factor II
4.
Blood Coagulation Factor II
5.
Differentiation Reversal Factor
6.
Factor II, Coagulation
7.
Factor, Differentiation Reversal
8.
II, Coagulation Factor
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Headache | FAERS: 2 | US FAERS | |
| 2 | Oral mucosal exfoliation | FAERS: 1 | US FAERS | |
| 3 | Pain | FAERS: 1 | US FAERS | |
| 4 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 5 | Product substitution issue | FAERS: 1 | US FAERS | |
| 6 | Protein urine present | FAERS: 1 | US FAERS | |
| 7 | Dizziness | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.